Submit Manuscript  

Article Details

Gene Therapy for Osteoinduction

[ Vol. 4 , Issue. 3 ]


Sanjay Kumar and Selvarangan Ponnazhagan   Pages 287 - 296 ( 10 )


Various disorders of bone and mineral metabolism are diagnosed to be defective in genes related to cellular growth and differentiation. Gene therapy to introduce normal copy of defective genes into cells and tissues to compensate for silent, minimally expressed or mutated genes can be accomplished by multiple approaches. Although each bone disease / disorder would require a case-wise evaluation of potential strategies for best possible outcome, considerations for the gene therapy approaches are: 1) introduction of a therapeutic gene into cells without changing any of its native biological properties, 2) minimal or total absence of immunogenic and toxic effects from introduced vectors, geneticallymodified cells or conditionally-expressed proteins, while achieving a therapeutic effect, 3) cell-type or tissue-specific, regulated expression of a therapeutic protein, and 4) restricting or abolishing the expression of disease triggering genes at the RNA or DNA levels. Although most of the currently available therapies for osteoinduction are pharmacological in nature, molecular understanding of biologically-driven factors provides greater opportunity to test their potential as therapeutic proteins. Strategies of gene therapy complement this approach through efficient delivery of genes encoding therapeutic proteins to target sites. The present review will attempt to give a comprehensive account of existing therapies for osteoinduction and discuss the potential and limitation of vector-mediated gene therapy for bone diseases.


gene therapy, osteoblasts, osteoclasts, viral vectors, non-viral vectors, osteoinduction, osteoporosis


Department of Pathology, LHRB 513, 701, 19th Street South, University of Alabama at Birmingham,Birmingham, AL 35294-0007, USA.

Read Full-Text article